Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05382273 · ClinicalTrials.gov registry record

Cannabis Tolerance Break Resource Study: T-Break Guide

A clinical trial of Cannabis Use and Tolerance, sponsored by University of Vermont.

Completed
Registry status
151
Enrollment target
1
Study location

NCT05382273 is a study of Cannabis Use and Tolerance that has completed, run by University of Vermont. The registered enrollment target is 151 participants, below the 276-participant average among 44 other Cannabis Use trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05382273, a study of Cannabis Use and Tolerance, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
151 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot study is to conduct research into the value of using the T-Break Guide for assisting people taking a tolerance break from cannabis. The hope is that this initial research will yield some insights and benchmarks into the Guide's efficacy, and provide a foundation for a later randomized control study. The following are some key research questions: 1. How did participants use the Guide? (Eg: daily; read once; 'a la carte') 2. How did using the Guide increase fidelity to tolerance break (starting, continuing, completing a break)? 3. Did using the Guide yield any benefits beyond tolerance break fidelity? (Eg: insight into patterns of use)

Interventions

  • BEHAVIORAL T-Break Guide

Study Locations (1)

Vermont

  • University of Vermont - Burlington

Trial Details

FieldValue
Enrollment Target 151 participants
Start Date 2021-04-22
Est. Completion 2021-08-01

Sponsor

University of Vermont

162 total trials

What the Registry Record Tells You About NCT05382273

The ClinicalTrials.gov registry entry for NCT05382273 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 276-participant average among 44 other Cannabis Use trials with a reported enrollment target (45% lower). The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cannabis Use appearing as the primary indexed condition, and to 1 intervention - of which T-Break Guide is the first listed.

NCT05382273 reports 1 study location spanning 1 distinct geographic area - top geographies include Vermont.

Frequently Asked Questions

What is clinical trial NCT05382273 about?

NCT05382273 is a clinical study titled "Cannabis Tolerance Break Resource Study: T-Break Guide". The purpose of this pilot study is to conduct research into the value of using the T-Break Guide for assisting people taking a tolerance break from cannabis. The hope is that this initial research will yield some insights and benchmarks into the Guide's efficacy, and provide a foundation for a later...

What is the current status of trial NCT05382273?

This trial is currently completed. The enrollment target is 151 participants. The study started on 2021-04-22. Estimated completion is 2021-08-01.

What conditions does trial NCT05382273 study?

This clinical trial studies the following conditions: Cannabis Use, Tolerance, Cannabis Withdrawal.

What interventions are being tested in trial NCT05382273?

The interventions under investigation include: T-Break Guide (BEHAVIORAL).

Who is sponsoring clinical trial NCT05382273?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05382273 being conducted?

This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cannabis Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.